KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Payables (2017 - 2025)

Elanco Animal Health (ELAN) has disclosed Payables for 9 consecutive years, with $368.0 million as the latest value for Q4 2025.

  • Quarterly Payables rose 24.32% to $368.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $368.0 million through Dec 2025, up 24.32% year-over-year, with the annual reading at $368.0 million for FY2025, 24.32% up from the prior year.
  • Payables hit $368.0 million in Q4 2025 for Elanco Animal Health, up from $352.0 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $506.0 million in Q2 2021 to a low of $259.0 million in Q3 2024.
  • Historically, Payables has averaged $358.2 million across 5 years, with a median of $361.0 million in 2023.
  • Biggest five-year swings in Payables: surged 108.66% in 2021 and later crashed 30.77% in 2023.
  • Year by year, Payables stood at $416.0 million in 2021, then dropped by 6.25% to $390.0 million in 2022, then plummeted by 30.77% to $270.0 million in 2023, then rose by 9.63% to $296.0 million in 2024, then increased by 24.32% to $368.0 million in 2025.
  • Business Quant data shows Payables for ELAN at $368.0 million in Q4 2025, $352.0 million in Q3 2025, and $368.0 million in Q2 2025.